This analysis set to find out two main objectives;
a) To describe twelve-months retention amongst HIV-1 infected individuals initiating highly active antiretroviral therapy in the year 2018
b) To determine initial virologic suppression amongst HIV-1 infected individuals initiating highly active antiretroviral therapy in the year 2018
Comments are closed